APPELATION APPROUVÉE DE OU DE LA MALADIE 11-ß-prostaglandin F2α 21-Hydroxylase Antibodies, Serum [OH21] 68kD (hsp-70) [F68KD] a1-acid glycoprotein autoimmume adrenal failure autoimmune hearing loss Obsolete name: orsomucoid urine, collect 4 C, 25 ml 50% Hac Red Top; store serum frozen Red Top (preferred); Gold SST. Store at -20 C. serum Available at CHUM qualitative antibody test Hospitals In Common ABCC6 Gene Analysis in Pseudoxanthoma Elasticum ABCC6 (603234) Pseudoxanthoma Elasticum (264800) Tier 1: sequencing for commom mutations [2641]; Tier 2: full gene sequencing [2642]; del/dupl (MLPA) [906] GeneDx (www.genedx.c Acetaminophen Acetazolamide Acetylcholine Receptor Antibody quantitation; to determine clearance serum Red Top (not SST) Red Top; Gold SST. Store and send serum at -20 C. RIA Hospitals-In-Common Hospitals-In-Common Acides biliaires totaux [30535] bile salts Serum, fasting; Separate; Stable 1 week at 4 C or Store frozen Bio-Quant (enzymatic) CHUM (ST. LUC) Adalimumab Humira Serum. Stable 48 h at RT, 5 days at 4 C, or 30 days at -20 C. ELISA Gamma-Dyncare Adenosine Deaminase levels Green top (Na or Li heparin). Maintain at room tempertaure. Immunology Service Laboratory. Hospital for Sick Children ADH Gold SST Sacre Coeur ADmark Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) [177] Alzheimer Disease (104300) Cerebrospinal Fluid (CSF), 2 ml. Store at -20 C. ELISA (www.athenadiagnostics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 1 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Adrenal hyperplasia due to 21-hydroyxlase deficiency (201910) CYP21A2 (613815) sequencing & MLPA Alberta Mol Dx Laboratory (Calgary) Adrenal hyperplasia, congenital, due to steroid 11-betahydroxylase deficiency; Hypoaldosteronism congenital due to CMO I deficiency CYP11B1 (610613); CYP11B2 (124080) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c AGXT Gene, Full Gene Analysis [AGXMS] AGXT (604285) Hyperoxaluria, primary, type 1 (259900) and MLPA ALPHA-1-ANTITRYPSIN DEFICIENCY (613490) SERPINA1 (104400) ALPHA-1- ANTITRYPSIN DEFICIENCY (613490) Attn: Norine Freedman or Lynn Coleman Special Chemistry Laboratory St Paul s Hospital 1081 Burrard Street Vancouver, B.C. V6Z 1Y6. Contact Dr. A. Mattman BEFORE sending sample. alpha-actin (skeletal muscle form)-related myopathy via the ACTA1 gene [358] ACTA1 (102610) nemaline myopathy (NEM3; OMIM #161800) and congenital fiber-type disproportion (CFTD1; OMIM #255310) (www.preventiongenetics.c Alpha-Subunit Pituitary Tumor Marker, Serum [APGH] Alternate name: Alpha Glycoprotein Subunit Red top Alzheimer disease, early form (104300) PSEN1 (104311) ALZHEIMER DISEASE, FAMILIAL, 1 (104300) and MLPA Labor MVZ Westmecklenberg (www.medlabor-wm.de) Alzheimer disease, early form (104300) PSEN2 (600759) ALZHEIMER DISEASE, FAMILIAL, 1 (104300) Labor MVZ Westmecklenberg (www.medlabor-wm.de) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 2 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Alzheimer disease, early form (104300) APP (104760) ALZHEIMER DISEASE, FAMILIAL, 1 (104300) and MLPA Labor MVZ Westmecklenberg (www.medlabor-wm.de) Aminolevulinic Acid Dehydratase (ALAD), Whole Blood [ALAD ] Aminolevulinic Acid Dehydratase Deficiency Porphyria (612740) Green Top, 4 C only Amphiphysin Paraneoplastic Disease Profile Gold SST Mitogen Advanced Diagnostics AMYOTROPHIC LATERAL SCLEROSIS PANEL [155] ANG (105850); C9orf72 (614260); FUS (137070); OPTN (602432); SOD1 (147450); TARDBP (605078) Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis (105550), Amyotrophic Lateral Sclerosis Type 6 (608030); Amyotrophic Lateral Sclerosis Type 9 (611895); Amyotrophic Lateral Sclerosis Type 1 (105400); Amyotrophic Lateral Sclerosis Type 10 (612069); Amyotrophic Lateral Sclerosis Type 12 (613435) and acgh (www.preventiongenetics.c Antdiuretic Hormome Plasma (EDTA); handle at 4 C; freeze plasma in plastic container Hopital Sacre-Coeur, QC File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 3 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Anti-C1q Antibody, IgG [ANTI-C1Q] Serum separator tube. Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 ml serum to an ARUP Standard Transport Tube. (Min: 0.15 ml). Store at 4 C. Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Semi-Quantitative Enzyme-Linked Immunosorbent Assay ARUP Laboratories (www.aruplab.c Anticorps anti-21 hydroxylase Anti-Enterocyte Antibody autoimmume adrenal failure Gold SST; store serum at -20 C Serum CHUM The Children's Hospital of Philadelphia Anti-HMGCR statin-related myopathy Gold SST Mitogen Advanced Diagnostics Anti-myelin associated glycoproteins (anti- MAG) WB Anti-p140/p155/TRIM28 Anti-PLA2R Paraneoplastic Disease Profile idiopathic membranous nephropathy Gold SST Gold SST Gold SST; store serum at -20 C Mitogen Advanced Diagnostics Mitogen Advanced Diagnostics Mitogen Advanced Diagnostics Anti-RNA pol I/III Gold SST Mitogen Advanced Diagnostics Apert/Pfeiffer Syndrome (recurrent mutation in FGFR1 gene) FGFR1 (136350); FGFR2 (176943) Craniosynostosis: Apert syndrome (101200), Pfeiffer syndrome (101600) : FGFR2 (exon 7); FGFR1 (p.pro252arg) Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 4 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Ataxia/Episodic Ataxia Disorders NextGen DNA Sequencing Panel (33 genes; includes whole mtdna sequencing) [NGS324] ABCB7 (300135); ADCK3 (606980); AFG3L2 (604581); APTX (606350); ATM (607585); CACNA1A (601011); CACNB4 (601949); CLPP (601119); CSTB (601145); FGF14 (601515); FLVCR1 (609144); FXN (606829); HARS2 (600783); ITPR1 (147265); KCNA1 (176260); KCNC3 (176264); KCND3 (605411); LARS2 (604544); MTPAP (613669); OPA1 (605290); PDYN (131340); PRKCG (176980); SACs (604490); SETX (608465); SIL1 (608005); SLC1A3 (600111); SPTBN2 (604985); SYNE1 (608441); TDP1 (607250); TGM6 (613900); TPP1 (607998); TTBK2 (611695); VAMP1 (185880) NextGen Sequencing Medical Neurogenetics (www.medicalneurogenetics.c Autoimmune Dysautonomia Evaluation, Serum (ADE) Autoimmune Inflammatory Myopathy/Myositis Profile Jo-1, Mi2, PL7, PL12, Pm/Scl75, PM/Scl100, Ku, SRP, Ro52, EJ, OJ Red Top Gold SST IFA, RIA, EIA, WB, CBA Mitogen Advanced Diagnostics Autoimmune Neurological Diseases Profile GM1 (IgG,IgM), GM2, GD1a, GT1b (IgG,IgM), GM3 (IgG, IgM), GQ1b (IgG,IgM), GD1b (IgG,IgM) Gold SST Mitogen Advanced Diagnostics File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 5 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Autoimmune Paraneoplastic Diseases Profile (paraneoplastic ataxia, encephalomyelitis) Autoimmune polyendocrinopathy syndrome, type I (240300) Autosomal dominant lateral temporal lobe epilepsy (Epilepsy, familial temporal lobe, 1) (600512) Amphiphysin, Ri, Yo. Hu, PNMA2 (Ma2/Ta), CV2/CRMP-5, Recoverin, SOX1, tintin Gold SST; CSF Mitogen Advanced Diagnostics AIRE (607358) GeneDx LGI-1 (604619) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c AUTOSOMAL RECESSIVE LIMB GIRDLE MUSCULAR DYSTROPHY SANGER SEQUENCING PANEL (253600; 253601;254130;607155;611307; 613319; 608099; 604286; 601954; 253700; 601287; 608807) [360] SGCD (601411); TRIM32 (602290); SGCG (608896); CAPN3 (114240); DYSF (603009); FKFP (606596); SGCA (60119); SGCB (600900); TTN (188840); TCAP (604488); ANO5 (608662) Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 ml serum to an ARUP Standard Transport Tube. (Min: 0.15 ml) (www.preventiongenetics.c Avian Precipitins: Budgie Red Top; Gold SST Counter Immunoelectrophoresis Hospitals-In-Common Avian Precipitins: Chicken Red Top; Gold SST Counter Immunoelectrophoresis Hospitals-In-Common Avian precipitins: Pigeon Red Top; Gold SST Azithromycin TDM Serum Baller-Gerold syndrome (218600) RECQL4 (603780) Barium Alternate: Hospitals-In- Common Urine - metal free container Counter Immunoelectrophoresis 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Hospitals-In-Common National Jewish Health Laboratories Centogene AG (www.centogene.c INSPQ File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 6 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Basal ganglia calcification, idiopathic, 3 (614540) SLC20A2 (158378) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c Benign Recurrent Intrahepatic Cholestasis Type 2 (605479) ABCB11 (603201) Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Birt-Hogg-Dubé Syndrome (135150) FLCN (607273) Alberta Mol Dx Laboratory (Calgary) Birt-Hogg-Dubé Syndrome (135150) FLCN (607273) deletion/duplication Alberta Mol Dx Laboratory (MLPA) (Calgary) Breast-Ovarian Cancer, Familial, type 1 (604370) BRCA1 (113705) Mount Sinai Hospital Breast-Ovarian Cancer, Familial, type 2 (612555) BRCA2 (600185) Mount Sinai Hospital Bromide C1 Esterase Inhibitor: Functional Plasma (Citrate).Separate and freeze as soon as possible. Store and send frozen. Specify "Functional" on requisition. Radial immunodiffusion Hospitals-In-Common C1q Complement Component. Separate platelet-poor plasma immediately. Freeze as soon as possible. Store and send frozen. If the specimen thaws, it is unsuitable for analysis. Formerly at Hospitals-In- Common, now available at CHUQ C9ORF72 (FTD) DNA Test [209] C9orf72 (614260) Amyotrophic lateral sclerosis and/or frontotemporal dementia repeat expansion (www.athenadiagnostics.c CACNA1A Full Gene Sequencing Analysis [MOL033] CACNA1A (601011) Familial hemiplegic migraine 1 (141500); episodic ataxia type 2 (108500) Medical Neurogenetics (www.medicalneurogenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 7 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE CACNA1S DNA Sequencing Test [641] CACNA1S (114208) Hypokalemic Periodic Paralysis (HOKPP) full gene sequencing (www.athenadiagnostics.c CACNB4 Full Gene Sequencing Analysis [MOL227] CACNB4 (601949) Episodic ataxia, type 5 (613855) CADASIL (125310) NOTCH3 (600276) Calpain 3 DNA Sequencing Test CAPN3 (114240) LGMD2A (253600), Calpainopathy Medical Neurogenetics (www.medicalneurogenetics.c London Laboratories Service Group (www.athenadiagnostics.c Calprotectine fécale [30536] random stool L'Hôpital Maisonneuve-Rosement Carnitine Palmitoyltransferase II (CPT2) Deficiency CPT2 (600650) Myopathy due to CPT II deficiency (255110) Lavender-top (EDTA) tube CPT2 Gene Sequencing (334) [] GeneDx CASPR2 Antibody Test Paraneoplastic Disease Red Top or Gold SST Cathartic Laxatives Profile, Stool [FCLPS] Mg, Pi Stool CAVEOLINOPATHY TESTING VIA THE CAV3 GENE [467] CDKN2A (p16) & CDK4 (Exon2) Sequencing CAV3 (601253) CDKN2A (600160); CDK4 (123829) Muscular Dystrophy, Limb-Girdle, Type 1C (607801) Melanoma, cutaneous malignant, 3 (www.athenadiagnostics.c (www.preventiongenetics.c GeneDx CEREBRAL CAVERNOUS MALFORMATIONS SANGER SQUENCING PANEL [120] KRIT (604214), CCM2 (607292), PCCD10 (609118) Cerebral Cavernous Malformations 1(116860), Cerebral Cavernous Malformations 2 (603284), Cerebral Cavernous Malformations 3 (603285) 1. CCM2 Sanger Sequencing 2. PDCD10 Sanger Sequencing 3. KRIT1 Sanger Sequencing 4. CCM2 Targeted Deletion via PCR (www.preventiongenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 8 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE CEREBRAL CAVERNOUS MALFORMATIONS VIA THE CCM2 GENE (603284) [122] CCM2 (607929) Cerebral calvernous malformations-2 (www.preventiongenetics.c CEREBRAL CAVERNOUS MALFORMATIONS VIA THE KRIT1/CCM1 GENE [121] KRIT1 (604241) Cerebral calvernous malformations-1 (116860) (www.preventiongenetics.c CEREBRAL CAVERNOUS MALFORMATIONS VIA THE PDCD10/CCM3 (603285) [123] PDCD10 (609118) Cerebral calvernous malformation-3 (www.preventiongenetics.c Cerebrotendinous xanthomatosis (213700) CYP27A1 (606530) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 9 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE CHARCOT MARIE TOOTH DISEASE; 42 GENES + MTDNA [NGS345] AARS (601065); AIFM1 (300169); ARHGEF10 (608236); BAG3 (603883); BSCL2 (606158); CTDP1 (604927); DHTKD1 (614984); DNM2 (602378); EGR2 (129010); FGD4 (611104); FIG4 (609390); GAN (605379); GARS (600287); GDAP1 (606598); GJB1 (304040); GNB4 (610863); HINT1 (601314); HK1 (142600); HSPB1 (602195); HSPB8 (608014); INF2 (610982); KARS (601421); KIF1B (605995); LITAF (603795); LMNA (150330); LRSAM1 (610933); MED25 (610197); MFN2 (608507); MPZ (159440); MTMR2 (603557); NDRG1 (605262); NEFL (162280); PDK3 (602526); PMP22 (601097); PRPS1 (311850); PRX (605725); RAB7A (602298); SBF2 (607697); SH3TC2 (608206); SLC12A6 (604878); TFG (602498); TRPV4 (605427); YARS (603623) Charco-Marie tooth Disease (302800) Next-Generation sequencing Medical Neurogenetics (www.medicalneurogenetics.c Charcot-Marie-Tooth disease, type 2A2 (609260) MFN2 (608507) Charcot-Marie-Tooth neuropathy, X-linked dominant (302800) GJB1 (304040) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 10 of 57 Charcot-Marie-Tooth Type 1A (118220) PMP22 (601097) deletion/duplication Charcot-Marie-Tooth Type 1A (118220) PMP22 (601097) London Health Sciences Centre, Molecular Diagnostic Laboratory Laboratory of Human Genetics (QC) Laboratory of Human Genetics (QC) Alberta Mol Dx Laboratory (Calgary)
APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Charcot-Marie-Tooth Type 1B (118200) MPZ (159440) Cholestanol Cerebrotendinous xanthomatosis Chondrosarcoma/Exostoses, multiple, type 1 and 2 EXT1 (608177); EXT2 (608210) and MLPA Alberta Mol Dx Laboratory (Calgary) Kennedy Kreiger Institute (Biochemical Genetics) Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital CLCN1 DNA Sequencing Test [128] CLCN1 (118425) Cockayne syndrome ERCC6 (609413); ERCC8 (609412) Myotonia congenita (160800 and 255700) COL4A5 Sequencing and Deletion Analysis (755) COL4A5 (303630) Alport syndrome (301050) Collagen Type II Antibodies [FFTYC] Red Top; Gold SST. Stable for 7 d at 4 C or longer at -20 C. and del/dupl Enzyme Linked Immunosorbent Assay (ELISA) (www.athenadiagnostics.c DNA Diagnostic Lab - Boston Children's Hospital (www.athenadiagnostics.c Colorectal cancer (Li-Fraumeni syndrome) (151623) TP53 (191170) 1. 2. gene dosage Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Complement Based Renal Disease (C3 Sequencing) C3 (120700) Hemolytic uremic syndrome, atypical, susceptibility to, 5 (612925). Part of Panel B: C3, THBD, APLN Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 11 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Complete PKD Evaluation [761] PKD1 (601313); PKD2 (173910) Polycystic kidney disease, adult type 1 (173900); Polycystic kidney disease 2 (613095) PKD1 and PKD2 DNA Sequencing and Deletion Analysis (www.athenadiagnostics.c Complete Tuberous Sclerosis Evaluation [TSC1 DNA Seq., TSC1 Deletion, TSC2 DNA Seq., TSC2 Deletion] [556] TSC1 (605284); TSC2 (191092) Tuberous sclerosis-1 (191100); Tuberous sclerosis-2 (613254) and del/dupl (www.athenadiagnostics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 12 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Comprehensive Intellectual Disability NextGen DNA Sequencing Panel (191 genes; includes whole mtdna sequencing) [NGS325] AAAS (605378); ABCC8 (600509); ACADSB (600301); ACSL4 (300157); ADSL (608222); AFF2 (300806); AGTR2 (300034); ALDH5A1 (610045); ANK3 (600465); AP1S2 (300629); ARHGEF6 (300267); ARHGEF9 (300429); ARID1A (603024); ARID1B (614556); ARX (300382); ASMT (300015); ASPM (605481); ATIC (601731); ATP6AP2 (300556); ATP7A (300011); ATRX (300032); AUTS2 (607270); BCOR (300485); BRAF (164757); BRWD3 (300553); C3orf58 (612200); CACNA1F (300110); CACNG2 (602911); CASK (300172); CC2D1A (610055); CDH15 (114019); CDK5RAP2 (608201); CDKL5 (300203); CENPJ (609279); CHD8 (610528); CLIC2 (300138); CLPP (601119); CNTN3 (601325); CNTN4 (607280); CNTNAP2 (604569); CRADD (614499); CRBN (609262); CUL4B (300304); DAB1 (603448); DCX (300121); DKC1 (300126); DLG3 (300189); DLGAP2 (605438); DOCK8 (611432); DRD2 NextGen Sequencing Medical Neurogenetics (www.medicalneurogenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 13 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE CONGENITAL MUSCULAR DYSTROPHY NEXTGEN SEQUENCING (NGS) PANEL [1301] ITGA7 (600536); FKTN (607440); FKRP (606596); (LAMA2 (156225); LARGE (603590); POMT1 (607426); POMT2 (607439); POMGNT1 (606822); DAG1 (128239); DPM1 (603503); DPM3 (605951); CHKB (612395); ISPD (614631); LMNA (150330); GTDC2 (614828); TMEM5 (605862); B3GALNT2 (610194); GMPPB (615320); B3GNT1 (605517); GOSP2 (604027); SGK196 (615247); ST3GAL4 (104240) Muscular Dystrophy- Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 10; MDDGA10 (615041); Congenital Disorder Of Glycosylation Type 1E (608799); Congenital Disorder Of Glycosylation Type 1O( 612937); Muscular dystrophydystroglycanopathy (limbgirdle), type C, 14(615352);Muscular dystrophydystroglycanopathy (congenital with brain and eye anomalies), type A, 12 (615249) Muscular dystrophydystroglycanopathy (congenital with brain and eye anomalies), type A, 13 (615287); Muscular dystrophydystroglycanopathy (congenital with brain and eye anomalies, type A, 11 (615181); Congenital Muscular Dystrophy- Dystroglycanopathy (With Brain And Eye NextGen Sequencing (22 genes) (www.preventiongenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 14 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE CONGENITAL MYASTHENIC SYNDROME NEXTGEN SEQUENCING (NGS) PANEL [1323] COLQ (603033); CHRNA1 (100690); CHRNB1 (100710); CHRND (100720); CHRNE (100725); MUSK (601296); CHAT (118490); DOK7 (610285); RAPSN (601592); SCN4A (603967) Congenital Myasthenic Syndrome, Acetazolamide- Responsive (614198); Myasthenic Syndrome, Congenital, Associated With Episodic Apnea (254210); Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency (608931);Myasthenic Syndrome, Congenital, Fast-Channel (608930); Congenital Myasthenic Syndrome, Slow Channel (601462) Next-gen Sequencing (www.preventiongenetics.c Cortical Brain Malformations Panel [698] ARFGEF2 (605371), ARX (300382), DCX (300121), EOMES (604615), FKRP (606596), FKTN (607440), FLNA (300017), GPR56 (604110), LAMC3 (604349), LARGE (603590), NDE1 (609449), OCLN (602876), PAFAH1B1 (601545), POMGNT1 (606822), POMT1 (607423), POMT2 (607439), RELN (600514), SRPX2 (300642), TUBA1A (602529), TUBA8 (605742), TUBB2B (612850), TUBB3 (602661), VLDLR(192977) Lisencephaly: Lissencephaly and subcortical band heterotopia (SBH), Alphadystroglycanopathies, Periventricular nodular heterotopia (PVNH); Polymicrogyria Exon Array CGH, Next-gen Sequencing GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 15 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Cortisol, free [FCORT] Red Top or Craniosynostosis Non-Syndromic (select exons of FGFR3 gene) FGFR3 (134934) Craniosynostosis ; FGFR3 (p.pro250arg) Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Creatine Disorders Panel, Urine [CRDPU] GATM (602360); SLC6A8 (300036) arginine:glycine amidinotransferase deficiency (602360/612718), guanidinoacetate methyltransferase deficiency (601240/612736), creatine transporter (SLC6A8) defect (300036/300352) Random urine Crouzon Syndrome (select exons of FGFR2 and FGFR3 gene) FGFR2 (176943); FGFR3 (134934) Craniosynostosis: Crouzon syndrome (123500) : FGFR2 (exon 7 and 8); FGFR3 (p.pro250arg) Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 16 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Cryoglobulin and Cryofibrinogen Panel, Serum and Plasma [CRGSP] CSF Protein Immunoassay Panel Evaluating patients with vasculitis, glomerulonephritis, and lymphoproliferative diseases Evaluating patients with macroglobulinemia or myeloma in whom symptoms occur with cold exposure Creutzfeldt-Jakob Disease (CJD) Cryofibrinogen Collection Container/Tube: Submission Container/Tube: Plastic vial Specimen Volume: 1 ml Collection Instructions: 1. Tube must remain at 37 degrees C. 2. Centrifuge at 37 degrees C. (Do not use a refrigerated centrifuge. If absolutely necessary, ambient temperature is acceptable.) It is very important that the specimen remain at 37 degrees C until after separation of plasma from red cells. 3. Place plasma into an appropriately labeled plastic vial. Cryoglobulin Collection Container/Tube: Red top Submission Container/Tube: Plastic vial Specimen Volume: 5 ml Collection Instructions: 1. Tube must remain at 37 degrees C. 2. Allow blood to clot at 37 degrees C. 3. Centrifuge at 37 degrees C. (Do not use a refrigerated centrifuge If absolutely 2.0 ml CSF; Freeze sample as soon as possible after collection. Ship frozen on dry ice. immunofixation 14-3-3 protein testing of cerebrospinal fluid (CSF); S100 protein ELISA: Tau protein ELISA National Microbiology Laboratory, Health Canada (Winnipeg) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 17 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Currarino syndrome MNX1 (142994) Currarino syndrome (176450) Diagenos (www.diagenos.c CV2/CRMP-5 Paraneoplastic Disease Profile Gold SST Mitogen Advanced Diagnostics Cystatin C Serum Hospitals-In-Common Cystic Fibrosis (219700) CFTR (602421) 1. 2. gene dosage Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Cystinuria SCL3A1 (104614) Cystinuria (220100) Centogene AG (www.centogene.c Cystinuria SCL7A9 (604144) Cystinuria (220100) Centogene AG (www.centogene.c Cystinuria PREPL (609577) Cystinuria (220100) Centogene AG (www.centogene.c Cytochrome P450 2D6 (CYP2D6) Comprehensive CYP2D6 (124030) Cascade, Blood [2D6CB] Dabigratan Serum (Light blue top) Quest Diagnostics DARS2 Full Gene Sequencing Analysis [MOL094] DARS2 (610956) Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (611105) Alternate name: DARS2: Mitochondrial Aspartyl-tRNA Synthetase Deficiency Medical Neurogenetics (www.medicalneurogenetics.c Deletion 1p Chromosome1p36 deletion syndrome (607872) Green Top; RT only microarray Cytogenetics Laboratory, Hospital for Sick Children File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 18 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), Serum [DSG13] Pemphigus Red Top Screening test or monitoring patient with confirmed diagnosis Dexamethasone [FDXM] Red Top Dihydrotestosterone Red Top or Gold Top Hospitals-In-Common File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 19 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE DISTAL HEREDITARY MOTOR NEUROPATHY NEXTGEN SEQUENCING (NGS) PANEL [1359] ATP7A (300011); BSCL2 (606158); DCTN1 (601143); DNMT1 (126375); FIG4 (609390); GAN (605379); GARS (600287); HINT1 (601314); HSPB1 (602195); HSPB8 (6080140; IGHMBP2 (600502); LAS1L (0) MEGF10 (612453); REEP1 (609139); SETX (608465); SLC5A7 (608761); TRPV4 (605427) Distal Hereditary Motor Neuronopathy Type 2B (608634); Charcot-Marie- Tooth Disease Type 2F (606595); Distal Hereditary Motor Neuronopathy Type 2A (158590); Charcot-Marie- Tooth Disease, Type 2L (608673); Distal Hereditary Motor Neuronopathy Type 5 (600794); Charcot-Marie- Tooth Disease Type 2D (601472); Spastic Paraplegia 17 (270685); Spinocerebellar Ataxia Autosomal Recessive 1 (606002);Charcot-Marie- Tooth Disease Type 2C (606071); Spinal Muscular Atrophy, Distal, Congenital Nonprogressive (600175) ; Scapuloperoneal Spinal Muscular Atrophy (181405); NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B (607641);Perry Syndrome (168605); Charcot Marie Tooth Next Generation Sequencing (NGS) and technologies (www.preventiongenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 20 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Diuretic Screen, Urine [FDIRU] LISTE DES ANALYSES HORS-QUEBEC benzthiazide, bumetanide, chlorothiazide, chlorthalidone, furosemide, hydrochlorothiazide, hydroflumethiazide, and metolazone Random urine Drug Screen, Prescription/OTC, Urine [PDSU] Trifluoperazine (stelazine) Random urine Duchenne and Becker Muscular Dystrophy (310200 and 300376) DMD (300377) 1. 2. gene dosage Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Ehlers-Danlos syndrome, type I COL5A2 (120190) Connective Tissue Gene Test Ehlers-Danlos syndrome, type I and II COL5A1 (120215) Connective Tissue Gene Test Ehlers-Danlos syndrome, type I and II COL5A1 (120215) del/dupl Connective Tissue Gene Test Ehlers-Danlos syndrome, type IV (130050) COL3A1 (120180) Epidermolysis bullosa (226600) COL7A1 (120120) & del/dupl 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Connective Tissue Gene Tests Centogene AG (www.centogene.c Epilepsy, generalized, with febrile seizures plus, type 7 (613863) SCN9A (603415) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 21 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Epilepsy,comprehensive; 126 genes + mtdna [NGS385] ABAT (137150); ABCC8 (600509); ACADSB (600301); ACSF3 (614245); ADSL (608222); ALDH5A1 (610045); ALDH7A1 (107323); ALG11 (613666); ARHGEF9 (300429); ARX (300382); ATIC (601731); ATP6AP2 (300556); AUTS2 (607270); BOLA3 (613183); C10ORF2 (606075); CACNA1A (601011); CACNA1H (607904); CACNA2D2 (607082); CACNB4 (601949); CDKL5 (300203); CHRNA2 (118502); CHRNA4 (118504); CHRNB2 (118507); CLCN2 (600570); CLN3 (607042); CLN5 (608102); CLN6 (606725); CLN8 (607837); CNTNAP2 (604569); COG7 (606978); COG8 (606979); COL6A2 (120240); COQ2 (609825); COQ9 (612837); CPA6 (609562); CSTB (601145); CTSD (116840); D2HGDH (609186); DNAJC5 (611203); DPAGT1 (191350); DYRK1A (600855); EFHC1 (608815); EPM2A (607566); ETHE1 (608451); FARS2 (611592); FASTKD2 (612322); FH (136850); FOLR1 (136430); FOXG1 (164874); GABRA1 NextGen Sequencing Medical Neurogenetics (www.medicalneurogenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 22 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Erythrocytosis, family related EPOR (133171), VHL (608537), EGLN1(PHD2) (606425), EPAS1 (HIF2A) (603349) Erythrocytosis, familial, 1 (133100); Erythrocytosis, familial, 2 (263400); Erythrocytosis, familial, 3 (609820); Erythrocytosis, familial, 4 (611783). Panel: EPOR: 133171, VHL: 608537, EGLN1: 606425, EPAS1: 603349 MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany Ethambutol TDM Serum Everolimus, Blood [EVROL] TDM National Jewish Health Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 23 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Expanded Neuromuscular Disorders: Sequencing and Deletion/Duplication Panel[MM360] ACTA1, AMPD1, AMPD3, ANO5, BAG3, BIN1, BSCL2, CAPN3, CAV3, CFL2, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, CHRNG, COL6A1, COL6A2, COL6A3, COLQ, CRYAB, DAG1, DES, DMD, DNM2, DOK7, DYSF, EMD, FHL1, FKRP, FKTN, FLNC, GAA, GLE1, GNE, IGHMBP2, ISPD, ITGA7, LAMA2, LARGE, LDB3, LMNA, MTM1, MTMR14, MUSK, MYH2, MYH7, MYOT, NEB, PABPN1, PLEC, PLEKHG5, PMM2, POMGNT1, POMT1, POMT2, PTRF, PYGM, RAPSN, RYR1, RYR2, SCN4A, SEPN1, SGCA, SGCB, SGCD, SGCE, SGCG, SIL1, SYNE1, SYNE2, TCAP, TNNI2, TNNT1, TPM2, TPM3, TRIM32, TTN, VRK1 Muscular dystrophies, Congenital myopathies, Congenital myasthenic syndrome, Nemaline myopathy, Limb girdle muscular dystrophy, Emery-Dreifuss muscular dystrophy, Congenital muscular dystrophy, Cardiomyopathies, Myoadenylate deaminase deficiency, Erythrocyte AMP deaminase deficiency, Myofibrillar myopathy, Duchenne/Becker muscular dystrophy, Congenital disorder of glycosylation type 1a, Malignant hyperthermia susceptibility, Myoclonus dystonia, Marinesco- Sjogren syndrome, Distal arthrogryposis, NMD, Neuromuscular disorders Next-Generation sequencing and genetargeted CGH array (deletion/duplication analysis included in this panel: BIN1, BSCL2, CFL2, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, CHRNG, COLQ, DNM2, DOK7, FHL1, FLNC, GLE1, GNE, IGHMBP2, ISPD, MTM1, MTMR14, MUSK, MYH2, PLEKHG5, PTRF, PYGM, RAPSN, SCN4A, SYNE1, SYNE2, and VRK1) Emory Molecular Genetics Laboratory (genetics.emory.edu/egl/) Facioscapulohumeral Muscular Dystrophy (158900) DUX4 (D4Z4) (606009) deletion/duplication FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2 (158901) VIA THE SMCHD1 GENE [874] SMCHD1 (614982) Childern's Hospital of Eastern Ontario (www.preventiongenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 24 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Familial Hemophagocytic Lymphohistiocytosis (FHL), Autosomal Recessive; type 2 (603553), type 3 (608898), type 4 (603552) and type 5 (613101) FAMILIAL HYPERCHOLESTEROLEMIA SANGER SEQUENCING PANEL [875] Familial Limb Girdle Myasthenia Syndroma via the DOK7 gene [465] Fascioscapulohumeral Muscular Dystrophy 1A (FSHD) (158900) PRF1 (170280); UNC13D (MUNC13-4) (608897); STXBP2 (601717); RAB27A (603868); STX11 (605014) APOB (143890); LDLR (144010); PCKS9 (603776) DOK7 (610285) FOXC1 Gene Sequencing [1342] FOXC1 (601090) Friedreich's Ataxia DNA Sequencing Analysis [348] FXN (FRDA) (606829) Frontotemporal Dementia Evaluation [281] PRF1 and STX11 also at: Hospital for Sick Children Familial Hypercholesterolemia (143890); Hypercholesterolemia, Autosomal Dominant, Type B (144010); Hypercholesterolemia, Autosomal Dominant, 3 (603776) Myasthenia, Limb-Girdle, Familial (254300) and acgh DUX4 (FSHMD1A) (606009) deletion and haplotype GRN (138945), MAPT (157140), C9ORF72 (614260) Axenfeld-Rieger syndrome, type 3 and Rieger or Axenfeld anomalies (602482) Friedreich ataxia (229300). Hop. Saint- Justin - triplet expansion; North York - triplet expansion Frontotemporal Dementia (600274) Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) (www.preventiongenetics.c (www.preventiongenetics.c Childern's Hospital of Eastern Ontario GeneDx Lavender-top (EDTA) tube Fumarase deficiency (606812) FH (136850) fumarate hydratase For MAPT and GRN: DNA Sequencing; for C9ORF72: PCR Fragment Analysis by Capillary Electrophoresis and del/dupl (www.athenadiagnostics.c (www.athenadiagnostics.c GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 25 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Functional Panel (FH autoantibody, Hemolytic Assay, C3Nef, and soluble C5b-9 (smac)) Panel requires at least 2ml frozen serum & plasma ELSIA and other assays Molecular Otolaryngology & Renal Research Laboratory, U. of Iowa Carver College of Medicine Gabapentin Red Top Hospitals-In-Common GARS Full Gene Sequencing Analysis [MOL167] GARS (600287) Charcot-Marie-Tooth disease, type 2D (601427); Medical Neurogenetics Neuropathy, distal (www.medicalneurogenetics.c hereditary motor, type V (600794) Gaucher Disease (recurrent mutations) GBA (606463) Gaucher's Disease, Type 1 (230800); Gaucher Disease, Perinatal Lethal (608013); Subacute Neuronopathic Gaucher's Disease (230900); Gaucher Disease, Type IIIc (231005) Direct mutation analysis (9 mutations);akj 90% sensitivity; others 50-60% Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) GAUCHER DISEASE VIA THE GBA GENE [479] GBA (606463) Gaucher's Disease, Type 1 (230800); Gaucher Disease, Perinatal Lethal (608013); Subacute Neuronopathic Gaucher's Disease (230900); Gaucher Disease, Type IIIc (231005) (www.preventiongenetics.c GCK (MODY2) DNA Sequencing and DeletionTest GCK (138079) MODY2, Maturity-Onset Diabetes of Young (MODY) (125851) (www.athenadiagnostics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 26 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Gene dosage for FGFR2, FGFR3 & TWIST FGFR2 (176943); FGFR3 (134934); TWIST1 (601622) Craniosynostosis del/dupl Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) GFAP Full Gene Sequencing Analysis GFAP (137780) Alexander disease (203450) Medical Neurogenetics (www.medicalneurogenetics.c GH-RH Serum or EDTA plasma InterSceince Institute Gitelman syndrome (9263800) SLC12A3 (600968) (www.athenadiagnostics.c GLA gene dosage GLA (300644) Fabry Disease (301500) ; Store at RT or 4 C for up to 48 h after drawing. At 4 C for >48 h. MLPA Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) GLA gene sequencing GLA (300644) Fabry Disease (301500) ; Store at RT or 4 C for up to 48 h after drawing. At 4 C for >48 h. Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Glucagon ; freeze plasma ASAP Hospitals In Common File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 27 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid [GD65C] stiff-man syndrome, autoimmune cerebellitis and other acquired central nervous system disorders affecting gabaminergic neurotransmission CSF (4 C preferred) Immunoprecipitation Assay Glycogen Storage Disease V (McArdle disease) (232600) PYGM (608455) sequencing and del/dupl and del/dupl Emory Molecular Genetics Laboratory (genetics.emory.edu/egl/) Neurological Disease GQ1b (IgG+IgM) Gold SST Mitogen Advanced Diagnostics Profile Hyperoxaluria, primary, GRHPR Gene, Full Gene Analysis [GRHMS] GRHPR (604296) type II (296000) and. MLPA Haloperidol Red Top or Green Top Hospitals In Common Hearing Loss: Branchio-Oto-Renal (BOR) Syndrome (115630) EYA1 (601653) 1. EYA1 gene sequencing 2. EYA1 gene dossage Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Hearing Loss: Non-Syndromic (Connexin 26 & 30) GJB2 (121011); GJB6 (604418) 1. GJB2 sequencing and GJB6 deletion 2. GJB2 sequencing only Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 28 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Hemiplegic Migraine Evaluation CACNA1A (601011); ATP1A2 (182340); SCN1A (182389) Familial Hemiplegic Migraine Type I (CACNA1A) DNA Test (141500), Familial Hemiplegic Migraine Type II (ATP1A2) DNA Test (602481), Familial Hemiplegic Migraine Type III (SCN1A) DNA Test (Target Exon Analysis) (609634) (www.athenadiagnostics.c Heparin Induced Thrombocytopenia HEREDITARY BREAST CANCER VIA THE CHEK2 GENE [714] CHEK2 (604373) Hereditary Breast Cancer via the CHEK2 Gene (Li- Fraumeni syndrome) (114480) Red top. 4 ml. Draw blood into red-top vacutainer and allow to clot. Centrifuge and transfer serum to plastic tube. Freeze promptly. Serotonin Release Assay (SRA) and PF4/heparin EIA Platelet Immunology Laboratory, McMaster University (www.preventiongenetics.c Hereditary Diffuse Gastric Cance (Gastric cancer, familial diffuse, with or without cleft lip and/or palate) (137215) CDH1 (192090) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c HEREDITARY DIFFUSE GASTRIC CANCER (137215) VIA THE CDH1 GENE [798] CDH1 (192090) (www.preventiongenetics.c Hereditary Erythrocytosis Mutations [HEMP] EPOR (133171), VHL (608537), EGLN1(PHD2) (606425), EPAS1 (HIF2A) (603349) Erythrocytosis, familial, 1 (133100); Erythrocytosis, familial, 2 (263400); Erythrocytosis, familial, 3 (609820); Erythrocytosis, familial, 4 (611783). Panel: EPOR: 133171, EGLN1: 606425, EPAS1: 603349, As reflex VHL: 608537 File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 29 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Hereditary hemochromatosis, type 1 (235200) HFE (613609) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG (www.centogene.c Hereditary Hemorrhagic Telangiectasia ENG (131195), ACVRL1 (ALK1) (601284), SMAD4 (600993) Telangiectasia, hereditary hemorrhagic, type 1 (187300) (OSLER- RENDU-WEBER DISEASE);Telangiectasia, hereditary hemorrhagic, type 2 (600376); Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (175050) and MLPA Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Hereditary Hemorrhagic Telangiectasia (HHT), type 1 (187300) and type 2 (600376) ENG (131195); ACVRL1(ALK1) (601284) Lavender 1. ACVRL1 gene sequencing 2.ENG gene sequencing 3. SMAD4 gene sequencing 4. ACVRL1 and ENG gene dosage Molecular Genetics Laboratory, Hospital for Sick Children (www.sickkids.ca/paediatriclabo ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Hereditary Interstitial Kidney Disease (UMOD) DNA Sequencing Test [770] UMOD (191845) Familial juvenile hyperuricemic (or gouty) nephropathy (FJHN) (162000) and Medullary cystic kidney disease type II (MCKD2) (603820) (www.athenadiagnostics.c Histamine ; freeze plasma ASAP Histoplasma Antibody, Serum [SHSTO] Histoplasmosis Red Top Hospitals In Common File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 30 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Histoplasma Sereology Gold SST Alberta Provincial Laboratory HLA-B 1502 Genotype, Carbamazepine Hypersensitivity, Blood [HLA15] HNF4A (MODY1) DNA Sequencing and Deletion Test (125850) Holoprosencephaly-7 (610828) /Basal cell nevus syndrome (109400) /Gorlin syndrome HLA-B (142830) HNF1A (TCF1) (142410) PTCH1 (601309) Homocystinuria [1563] CBS (613381) Stevens-Johnson syndrome (608579) and toxic epidermal necrolysis (608579) Homocystinuria, B6- responsive and nonresponsive types (236200) & MLPA and del/dupl 1. 2.HD array HTRA1 DNA Sequencing Test (CARASIL) (600142) HTRA1 (602194) Hypercholestérolémie familiale (gène du récepteur LDL) LDLR (144010) Hyperglycosylated hcg Hyper-IgE Syndrome Panel [678] DOCK8 (614443), SPINK5 (605010), STAT3 (102582), TYK2 (176941) Familial Hypercholesterolemia (143890) First trimester screen for Down syndrome and trisomy 18 Hyper-IgE recurrent infection syndrome {147060); Hyper-IgE recurrent infection syndrome, autosomal recessive (243700); Netherton syndrome (256500); Tyrosine kinase 2 deficiency (611521) Gold SST Exon Array CGH, Next-gen Sequencing (www.athenadiagnostics.c GeneDx Connective Tissue Gene Tests (www.ctgt.net) (www.athenadiagnostics.c Hopital Ste. Justine Quest Laboratories GeneDx (www.genedx.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 31 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Hypertophic Cardiomyopathy Sequencing Panel [192600] ACTC (ACTC1) (102540), CAV3 (601253), GLA (300644), LAMP2 (309060), MTTG (590035), MTTI (590045), MTTK (590060), MTTQ (590030), MYBPC3 (600958), MYH7 (160760), MYL2 (160781), MYL3 (160790), PRKAG2 (602743), TNNC1 (191040), TNNI3 (191044), TNNT2 (191045), TPM1 (191010), TTR (176300) See (www.preventiongenetics.c Panel (overlap)., Next Gen sequencing GeneDx HYPERTROPHIC CARDIOMYOPATHY NEXTGEN SEQUENCING (NGS) PANEL [1313] ACTC1 (102540); ACTN2 (102573); CSSRP3 (600824); GLA (300644); LAMP2 (309060); MYBPC3 (600958); MYH7 (160760); MYL2 (160781); MYL3 (1607900; PRKAG2 (602743); TNNC1 (191040); TNNI3 (191044); TNNT2 (191045); TPM1 (191010); TTN (188840) See GeneDx Panel (overlap). [2 tubes] Next Generation Sequencing (NGS) and technologies (www.preventiongenetics.c Hypokalemic Periodic Paralysis, type 1 (170400) and type 2 (613345) CACNA1S (114208); SCN4A (603967) Sequence analysis of select exons Targeted mutation analysis Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital IA-2 Autoantibody Test Diabetes, type 1 Gold SST or Red Top (www.athenadiagnostics.c IBD sigi Diagnostic differnetiate among IBD types 2.0 ml Serum (Red Top or SST) and 2.0 ml Whole Blood EDTA / Tube Prometheus Therapeutics & Diagnostics Ibuprofen Red Top ARUP Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 32 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE IGF Binding Protein-1 (IGFBP-1) [FIGBP] Not: IGFBP-3 Draw blood in a plain, red-top tube(s). Spin down and separate within one hour. Ship 0.5 ml frozen in a plastic vial. IGF-II [FIGF2] Draw blood in a plain, red-top tube(s). Separate within 1 hour of collection,freeze immediately Inclusion body myopathy and autospmal recessive, ealrly onset myopathy via the MYH2 gene [361] MYH2 (160740) Inclusion Body Myopathy 3 (605637) (www.preventiongenetics.c Infliximab et Ac anti-infliximab [30098] Serum. Stable 48 h at RT, 5 days at 4 C, or 30 days at -20 C. ELISA L'Hôpital Maisonneuve-Rosement Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation [717] INF2 (601982); TRPC6 (603652); NPHS2 (604766); ACTN4 (604638) Glomerulosclerosis, focal segmental, 5 (613237); Glomerulosclerosis, focal segmental, 2 (603965); Nephrotic syndrome, type 2 ( 600995);Glomerulosclerosi s, focal segmental, 1 (603278) (www.athenadiagnostics.c Insulin-Like Growth Factor 1 [IGF-1] Red top Royal Victoria Hospital Integrin alpha 9 ITGA9 (603963) Storage/Transport Temperature not available Interferon Beta Neutralizing Antibodies In MS Patient Treated With IFN Gold SST Neuro-Immunology Laboratories (UBC) Interleukin-2 (IL-2), ELISA [FIL2] Draw sufficient blood in a plain, red-top tube(s). Spin down and pour off into a plastic, screwcapped tube. Freeze immediately. ELISA JAG1 Gene Sequencing & Del/Dup JAG1 (601920) Alagille syndrome (118450) GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 33 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Jaundice Chip multiple genes gene chip Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Joubert and Meckel-Gruber Syndromes via the CC2D2A gene [278] JUNCTIONAL EPIDERMOLYSIS BULLOSA (JEB) SANGER sequencing panel [975] Juvenile Polyposis Syndrome (610069 and 174900) CC2D2A (612013) Joubert syndrome 9 LAMC2 (150292); LAMA3 (600805); LAMB3 (150310); COL17A1 (113811) BMPR1A (601299); SMAD4 (600993) Tier 1: sequencing & del/dupl (www.preventiongenetics.c (www.preventiongenetics.c Juvenile Polyposis Syndrome (610069 and 174900) BMPR1A (601299) Tier 2: sequencing GeneDx Juvenile Polyposis Syndrome (610069 and 174900) Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome/juvenile polyposis syndrome, infantile form BMPR1A (601299); SMAD4 (600993) SMAD4 (600993); BMPR1A (601299) GeneDx Tier 3: del/dupl GeneDx Tier 1: sequecning and del/dupl GeneDx KCNA1 Full Gene Sequencing Analysis [MOL064] KCNA1 (176260) Episodic ataxia/myokymia syndrome Medical Neurogenetics (www.medicalneurogenetics.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 34 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE LAMINOPATHIES VIA THE LMNA GENE [347] LMNA (150330) Charcot-Marie-Tooth Disease Type 2B1 (605588); Limb-Girdle Muscular Dystrophy, Type 1B (159001); Lipodystrophy, Familial Partial, Dunnigan Type (151660); Dilated Cardiomyopathy 1A (115200); Emery-Dreifuss Muscular Dystrophy, Autosomal Dominan (151350)t; Restrictive Dermopathy, Lethal (275210); Hutchinson- Gilford Syndrome (176670) (www.preventiongenetics.c Lebers hereditary optic neuropathy (LHON) (535000) Also available: Alberta Mol Dx Laboratory (Edmonton) (2 x 4 ml) Targeted mutation analysis (nt.#3460g>a, nt.#11778g>a and nt.#14484t>c) London Health Sciences Centre, Molecular Diagnostic Laboratory File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 35 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Leigh disease and Leigh-like syndromes NextGen DNA Sequencing Panel (75 genes) [NGS351] LEMS (anti-vgcc) Antibody Test [475] Leukemia, Philadelphia chromosome-positive, resistant to imatinib AIFM1 (300169); ALDH5A1 (610045); ARX (300382); BCS1L (603647); C12orf65 (613541); COA5 (613920); COX10 (602125); COX14 (614478); COX15 (603646); COX6B1 (124089); CPT2 (600650); DLAT (608770); DLD (238331); ETHE1 (608451); FARS2 (611592); FASTKD2 (612322); FOXRED1 (613622); GCDH (608801); KCNQ2 (602235); LIAS (607031); LRPPRC (607544); MTFMT (611766); MUT (609058); NDUFA1 (300078); NDUFA10 (603835); NDUFA11 (612638); NDUFA12 (614530); NDUFA2 (602137); NDUFA9 (603834); NDUFAF1 (606934); NDUFAF2 (609653); NDUFAF3 (612911); NDUFAF4 (611776); NDUFAF5 (612360); NDUFAF6 (612392); NDUFB3 (603839); NDUFS1 (157655); NDUFS2 (602985); NDUFS3 (603846); NDUFS4 (602694); NDUFS6 (603848); NDUFS7 (601825); NDUFS8 (602141); NDUFV1 (161015); NDUFV2 (600532); NDUFV3 (602184); NUBPL (613621); PC (608786); ABL1 (189980) Leigh syndrome (256000); Leigh syndrome, X-linked (308930) Lambert-Eaton Myasthenic syndrome Red Top NextGen Sequencing Medical Neurogenetics (www.medicalneurogenetics.c (www.athenadiagnostics.c University Health Network (Toronto General Hospital) Levetiracetam ; transport on ice Hopital Ste. Justine File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 36 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE LHON mtdna Evaluation Leber's hereditary optic neuropathy (535000); multiple mitochondrial genes involved (www.athenadiagnostics.c LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) NEXTGEN SEQUENCING (NGS) PANEL [1345] ANO5 (608662); CAPN3 (114240); CAV3 (6012530; DES (125660); DNAJB6 (611332); DYSF (603009); FKRP (606596); GMPPB (615320); ISPD (614631); LIMS2 (607908); LMNA (150330); MYOT (604103); PNPLA2 (609059); SGCA (600119); SGCB (600900); SGCD (601411); SGCG (608896); SMCDH1 (614982); TCAP (604488); TNOP3 (610032); TOR1AIP1 (614512); TRAPPC11 (614138); TRIM32 (602290); TTN (188840) [2 tubes] NextGen Sequencing (24 genes) (www.preventiongenetics.c LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2B AND MIYOSHI MYOPATHY VIA THE DYSF GENE [342] LIMB GIRDLE MUSCULAR DYSTROPHY, TYPE 2L (LGMD2L)(611307) AND DISTAL MIYOSHI MYOPATHY (MMD3) (613319) VIA THE ANO5 GENE [469] DYSF (603009) Limb-Girdle Muscular Dystrophy, Type 2B (253601); Miyoshi Myopathy (254130), Myopathy, Distal, With Anterior Tibial Onset (606768) [2 tubes] ANO5 (608662) Loeys-Dietz syndrome (609192 and 608967) TGFBR1 (190181) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing (www.preventiongenetics.c (www.preventiongenetics.c Centogene AG (www.centogene.c File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 37 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE LOEYS-DIETZ SYNDROME VIA THE TGFBR2 GENE [397] Long QT Syndrome (LQTS) Sequencing and Gene Duplication Panel (192500) MAG 'Dual Antigen' Autoantibody Test TGFBR2 (190182) AKAP9 (604001), ANK2 (106410), CACNA1C (114205), CAV3 (601253), KCNE1 (176261), KCNE2 (603796), KCNE3 (604443), KCNH2 (152427), KCNJ2 (600681), KCNQ1 (607542), SCN4B (608256), SCN5A (600163), SNTA1 (601017) LISTE DES ANALYSES HORS-QUEBEC Loeys-Dietz syndrome 1B (610168); Loeys-Dietz syndrome 2B (610380) Anti-MAG neuropathy, Anti-SGPG neuropathy 1. Exon Array CGH, Next-gen Sequencing 2. Known mutation (specify mutation) Malignant hyperthermia susceptibility 1 (145600) RYR1 (180901) Mannose-binding protein deficiency MBL2 (154545) Mannose-binding protein deficiency (614372) Red Top 1. 2. deletion/duplication (www.preventiongenetics.c GeneDx (www.athenadiagnostics.c University Health Network (Toronto General Hospital) Centogene AG (www.centogene.c MAPT DNA Sequencing Test [205] MAPT (157140) Frontotemporal Dementia (600274) Marfan syndrome, type I (154700) FBN1 (134797) & del/dupl (www.athenadiagnostics.c Connective Tissue Gene Tests File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 38 of 57
APPELATION APPROUVÉE DE OU DE LA MALADIE Meckel-Gruber syndrome Sequencing Panel CC2D2A (612013); CEP290 (610142); MKS (609883); RPGRIP1L (610937); TCTN (613846)2; TMEM67 (609884); TMEM216 (613877) LISTE DES ANALYSES HORS-QUEBEC Meckel Syndrome, Type 8 (613885); Meckel Syndrome, Type 6 (312284); Meckel Syndrome, Type1 (249000); Meckel Syndrome, Type 4 (611134); Meckel Syndrome, Type 3 (607361); Meckel Syndrome, Type 5 (611561); Meckel syndrome 2 (603194) Melnick-Needles Syndrome (309350) FLNA (300017) MERRF (545000), MELAS (540000), NARP (551500) Mitochondrial DNA Sequencing Analysis, whole [MOL021] Mitochondrial diseases including: Leber hereditary optic neuropathy (LHON); Neuropath, ataxia, and retinitis pigmentosa (NARP); Myoclonic epilepsy associated with ragged-red fibers (MERRF); Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) & del/dupl Targeted mutation analysis NextGen Sequencing University of Chicago Genetic Services Laboratories (dnatesting.uchicago.edu) Emory Molecular Genetics Laboratory (genetics.emory.edu/egl/) Alberta Mol Dx Laboratory (Edmonton) Medical Neurogenetics (www.medicalneurogenetics.c MLPA (screen for deletions of CFHR1-CFHR3) CFHR1 (134371); CFHR3 (605336) Hemolytic uremic syndrome, atypical, susceptibility to (235400) MLPA Molecular Otolaryngology & Renal Research Laboratory, U. of Iowa Carver College of Medicine File Name: Gilfix-Lab Send Out List_Revised Updated 2014.07.28 sorted Page 39 of 57